Knowing which patients will benefit the most from health-related apps can be difficult, according to Michael Seid, PhD, director of Health Outcomes and Quality of Care Research at the James M. Anderson Center for Health Systems Excellence at Cincinnati Children's Hospital Medical Center.
Knowing which patients will benefit the most from health-related apps can be difficult, Michael Seid, PhD, director of Health Outcomes and Quality of Care Research at the James M. Anderson Center for Health Systems Excellence at Cincinnati Children's Hospital Medical Center, said at the US News Hospital of Tomorrow conference in Washington, DC.
The problem, he said, is that patients don’t always use the apps that will help them. Involving patients in the design of apps, will make the technology more useful.
“Technology is not the answer,” Dr Seid said. “Technology is a way to help people achieve their goals.”
Impact of Amivantamab-Lazertinib on EGFR, MET Resistance Alterations in NSCLC: Danny Nguyen, MD
September 15th 2025The combination of amivantamab and lazertinib in first-line non–small cell lung cancer (NSCLC) significantly reduces resistance mechanisms with implications for second-line treatment, said Danny Nguyen, MD, of City of Hope.
Read More
Disparities in Biomarker Testing Impact Nonsquamous NSCLC Outcomes: Surbhi Singhal, MD
September 6th 2025Surbhi Singhal, MD, of the University of California Davis, discussed disparities in biomarker testing among patients diagnosed with stage IV nonsquamous non–small cell lung cancer (NSCLC).
Read More